Copy number deletion of PLA2G4A affects the susceptibility and clinical phenotypes of schizophrenia

Zibo Gao,Xinru Guo,Zhouyang Sun,Songyu Wu,Qianyi Wang,Qianlong Huang,Wei Bai,Changgui Kou
DOI: https://doi.org/10.1038/s41537-024-00474-0
2024-05-31
Schizophrenia
Abstract:Phospholipase A2(PLA2) superfamily is recognized as being involved in the pathogenesis of schizophrenia by affecting lipid homeostasis in cell membranes. We hypothesized that PLA2 gene copy number variation (CNV) may affect PLA2 enzyme expression and be associated with schizophrenia risk. This study indicated that in the discovery stage, an increased copy number of PLA2G6 and the deletion of PLA2G3, PLA2G4A, PLA2G4F and PLA2G12F was associated with increased risk of schizophrenia. CNV segments involving six PLA2 genes were detected in publicly available datasets, including two deletion segments specific to the PLA2G4A gene. The relationship between the deletion of PLA2G4A and susceptibility to schizophrenia was then reaffirmed in the validation group of 806 individuals. There was a significant correlation between PLA2G4A deletion and the symptoms of poverty of thought in male patients and erotomanic delusion in females. Furthermore, ELISA results demonstrate a significant decrease in peripheral blood cytosolic PLA2(cPLA2) levels in patients with the PLA2G4A deletion genotype compared to those with normal and copy number duplicate genotypes. These data suggest that the functional copy number deletion in the PLA2G4A gene is associated with the risk of schizophrenia and clinical phenotypes by reducing the expression of cPLA2, which may be an indicator of susceptibility to schizophrenia.
psychiatry
What problem does this paper attempt to address?
This paper aims to explore the association between copy number variations (CNVs) of the phospholipase A2 (PLA2) superfamily genes and schizophrenia, particularly in the Chinese Han population. Specifically, the study found that the deletion of the PLA2G4A gene is significantly associated with susceptibility to schizophrenia and clinical phenotypes. ### Main Research Questions: 1. **Relationship between PLA2 gene CNVs and schizophrenia**: The study hypothesizes that CNVs of the PLA2 gene may affect the expression of PLA2 enzymes and be related to the risk of schizophrenia. 2. **Impact of PLA2G4A gene deletion**: The study focuses particularly on the deletion of the PLA2G4A gene, finding it associated with an increased risk of schizophrenia. 3. **Clinical phenotype association**: The study also explores the relationship between PLA2G4A gene deletion and "poverty of thought" symptoms in male patients and "erotomania" symptoms in female patients. ### Key Findings: - **PLA2G4A gene deletion**: The deletion of the PLA2G4A gene is significantly associated with an increased risk of schizophrenia. - **Enzyme level changes**: Patients with PLA2G4A gene deletion have significantly lower levels of cytosolic PLA2 (cPLA2) in their plasma. - **Gender differences**: In male patients, PLA2G4A gene deletion is significantly associated with "poverty of thought" symptoms; in female patients, it is significantly associated with "erotomania" symptoms. Through these findings, the study reveals that the deletion of the PLA2G4A gene may serve as a marker of susceptibility to schizophrenia, and its mechanism may involve changes in cPLA2 enzyme levels.